Last reviewed · How we verify

NCT03326115: AC PVP

Effectiveness of a Peer Visitation Program to Improve Patient Activation and Quality of Life During Amputation Rehabilitation

Status unknown NA Last updated 28 September 2020
What this trial tests

NA trial testing Peer Visitation Program in Amputation in 46 participants. Status unknown.

Timeline
1 December 2020
Primary endpoint
15 April 2021
1 August 2021

Quick facts

Lead sponsorProsthetic Design & Research
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment46
Start date1 December 2020
Primary completion15 April 2021
Estimated completion1 August 2021

Drugs / interventions tested

Conditions studied

Sponsor

Prosthetic Design & Research

Who can join

Adults 18 to 75, any sex, with Amputation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is no known interventional clinical trial evidence for existing support and the reintegration strategy of a peer visitation program following amputation. The Amputee Coalition Peer Visitation Program is the only national and VA recognized program for amputees, however, it has not been rigorously tested for effectiveness. Therefore, the objective of this study is to demonstrate the Amputee Coalition Peer Visitation Program (AC PVP) will improve functional outcomes for Service Members, Veterans, and civilians during amputation rehabilitation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Amputation

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03326115.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing